Latest investment in initiative to offer serialization services across PCI’s global network.
Contract manufacturer PCI Pharma Services initially announced its global serialization initiative in February 2017. Since then, the company has implemented serialization capabilities at sites in the US and Europe, including the installation of state-of-the-art equipment and a flexible and seamless data exchange system backed by skilled and trained serialization teams.
Most recently, PCI announced that its site near Dublin, Ireland, acquired in 2017 when the company purchased Millmount Healthcare, now has the capability to support the serialization needs of clients well in advance of the implementation dates for the European Falsified Medicines Directive (EU FMD).
PCI’s approach includes the use of machine and human-readable coding, tamper-evident solutions and Bollini labeling linked to a case-loading and aggregation station, with a final aggregation station connecting cases to pallets. The company, according to a recent press release, is “a strong supporter of the advanced use of aggregation to realize the significant benefits in packaging operations, as well as the broader pharmaceutical supply chain.”
The investment in serialization at the Ireland facility is part of a global initiative by PCI to offer serialization services across its global network. “This is an important addition to the site’s capabilities and PCI as a whole,” said Ian Parsonage, PCI’s Senior Director of Global Serialization. “Ensuring supply chain integrity and patient safety is of critical importance. We pride ourselves on real-life experience and expertise in this area and our commitment through such significant strategic investment continues to demonstrate and deliver a truly industry-leading solution for our customers.”
